12-133221317-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001372060.1(ANHX):c.1168G>A(p.Val390Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000215 in 1,535,878 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001372060.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANHX | NM_001372060.1 | c.1168G>A | p.Val390Met | missense_variant | 8/10 | ENST00000545940.6 | NP_001358989.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANHX | ENST00000545940.6 | c.1168G>A | p.Val390Met | missense_variant | 8/10 | 5 | NM_001372060.1 | ENSP00000439513.2 | ||
ANHX | ENST00000419717.3 | c.856G>A | p.Val286Met | missense_variant | 7/9 | 2 | ENSP00000409950.1 | |||
ANHX | ENST00000673940.1 | c.658G>A | p.Val220Met | missense_variant | 4/6 | ENSP00000501263.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152142Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000372 AC: 5AN: 134248Hom.: 0 AF XY: 0.0000274 AC XY: 2AN XY: 73072
GnomAD4 exome AF: 0.0000188 AC: 26AN: 1383736Hom.: 0 Cov.: 31 AF XY: 0.0000190 AC XY: 13AN XY: 682808
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152142Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74316
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 30, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at